文献速递临床试验与 GCP基础与转化研究

基于正念的干预对化疗后乳腺癌患者认知障碍的研究方案:三臂随机对照试验

A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial.
PubMed 文献 · Trials · 2020-03-23

主要结局为认知失败问卷测量的认知症状及注意网络功能连接变化,旨在评估正念干预对化疗后认知障碍的疗效与机制。

要点

  • 正念干预组与体能训练组均接受8周内4次团体课程,正念组每次3小时,体能组每次2小时。
  • 主要结局为认知失败问卷评估的认知症状和注意网络功能脑连接变化。
  • 次要结局包括情绪困扰、疲劳、正念、生活质量、神经认知测试、MRI脑结构与功能变化及炎症指标。

核心结论

  • 该研究方案旨在评估正念干预减少化疗后乳腺癌患者认知障碍的疗效与机制。
  • 若证实有效,正念干预可作为非药物、低门槛的心理健康干预改善癌症后认知障碍。

研究设计与样本

  • 三臂、平行组、随机对照试验,评估时间点为基线、干预后1至3周及3个月随访。
  • 随机分为正念干预组(n=40)、体能训练主动对照组(n=40)和常规治疗对照组(n=40)。
  • 正念干预与主动对照均为8周内4次团体课程,正念组每次3小时,体能组每次2小时。

关键数值与推荐

  • 主要结局为认知失败问卷测量的认知症状及注意网络功能脑连接变化。
  • 次要结局包括情绪困扰、疲劳、正念、生活质量水平、神经认知测试、MRI脑结构与功能变化及炎症指标。

临床怎么用

  • 为医疗保健提供者提供正念干预作为非药物、低门槛心理健康干预的潜在应用信息。
  • 若研究证实有效,可能改善癌症后患者的认知障碍与生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mindfulness has been applied to improve cancer care by enhancing psychological well-being. However, little is known about its impact on cognitive impairment experienced by cancer patients after chemotherapy. Mindfulness may be relevant in tackling cognitive impairment by decreasing emotional distress and fatigue, by decreasing inflammation, and by strengthening functional brain connectivity. The aim of the present study protocol is to evaluate the efficacy and mechanisms of a mindfulness-based intervention to reduce cognitive impairment in breast cancer patients after chemotherapy. METHODS/DESIGN: The present study is a three-arm, parallel-group, randomized controlled trial with assessments at baseline, 1 to 3 weeks after the intervention and at 3 months' follow-up. One hundred and twenty breast cancer patients who ended treatment a minimum of 6 months and a maximum of 5 years before, and who have cognitive complaints, will be enrolled. They will be randomized into one of the following three study arms: (1) a mindfulness-based intervention group (n = 40), (2) an active control condition based on physical training (n = 40), or (3) a treatment as usual (TAU) control group (n = 40). Both the mindfulness-based intervention and the active control condition consist of four group sessions (3 h for the mindfulness condition and 2 h for the physical training) spread over 8 weeks. The primary outcomes will be cognitive symptoms as measured by the Cognitive Failure Questionnaire and changes in functional brain connectivity in the attention network. Secondary outcomes will be (1) levels of emotional distress, fatigue, mindfulness, quality of life; (2) neurocognitive tests; (3) structural and functional brain changes using MR imaging and (4) measures of inflammation. DISCUSSION: The study will examine the impact of a mindfulness-based intervention on cognitive impairment in breast cancer patients. If the findings of this study confirm the effectiveness of a mindfulness-based program to reduce cognitive impairment, it will be possible to improve quality of life for ex-cancer patients. We will inform health care providers about the potential use of a mindfulness-based intervention as a non-pharmaceutical, low-threshold mental health intervention to improve cognitive impairment after cancer. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03736460. Retrospectively registered on 8 November 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Van der Gucht K, Melis M, Ahmadoun S, et al. A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial. Trials. 2020. PMID: 32293533. doi:10.1186/s13063-020-4204-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。